AFT-Leflunomide

Active ingredient:

Leflunomide 20mg;  

Available from:

AFT Pharmaceuticals Ltd

INN (International Name):

Leflunomide 20 mg

Dosage:

20 mg

Pharmaceutical form:

Film coated tablet

Composition:

Active: Leflunomide 20mg   Excipient: Colloidal silicon dioxide Crospovidone Lactose monohydrate Maize starch Opadry yellow 85F12305 Povidone Purified talc

Units in package:

Bottle, plastic, HDPE with PP screw cap, 30 tablets, 30 tablets

Class:

Prescription

Prescription type:

Prescription

Manufactured by:

Formosa Laboratories Inc.

Therapeutic indications:

AFT-LEFLUNOMIDE is indicated for treating rheumatoid arthritis, for improving signs and symptoms of the disease, for retarding joint destruction and also for improving functionality and the quality of life. AFT-LEFLUNOMIDE can be used with patients who have not responded to alternative treatments or as a first line treatment in patients who have a contraindication to other medicines.

Product summary:

Package - Contents - Shelf Life: Bottle, plastic, HDPE with PP screw cap, 30 tablets - 30 tablets - 24 months from date of manufacture stored at or below 25°C protect from light - Bottle, plastic, HDPE with PP screw cap, 100 tablets - 100 tablets - 24 months from date of manufacture stored at or below 25°C protect from light

Authorization date:

2005-09-20